A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients With Advanced Solid Tumors

Status:
Recruiting

Trial end date:
2024-10-15

Target enrollment:

Participant gender:

This is a Phase 1 study to assess the safety and clinical activity of KSQ-4279 alone and in combination in patients with advanced solid tumors.

Phase 1

KSQ Therapeutics, Inc.

Adenosine